These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 21447972)

  • 21. Management of recurrent testicular germ cell tumors.
    Sonpavde G; Hutson TE; Roth BJ
    Oncologist; 2007 Jan; 12(1):51-61. PubMed ID: 17227900
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Selected use of aggressive adjuvant chemotherapy in resected stage II nonseminomatous germ cell tumors of the testis.
    Pizzocaro G
    Prog Clin Biol Res; 1985; 203():585-90. PubMed ID: 2421344
    [No Abstract]   [Full Text] [Related]  

  • 23. Surgical management of low-stage nonseminomatous germ cell testicular cancer.
    Stephenson AJ; Klein EA
    BJU Int; 2009 Nov; 104(9 Pt B):1362-8. PubMed ID: 19840014
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bilateral testicular germ cell tumors in Turkey: increase in incidence in last decade and evaluation of risk factors in 30 patients.
    Akdogan B; Divrik RT; Tombul T; Yazici S; Tasar C; Zorlu F; Ozen H
    J Urol; 2007 Jul; 178(1):129-33; discussion 133. PubMed ID: 17499297
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Testicular cancer. Standard management leads to recovery in 90 to 95 percent of the cases].
    Berger N; Droz JP
    Rev Prat; 2007 Feb; 57(4):361-3. PubMed ID: 17455737
    [No Abstract]   [Full Text] [Related]  

  • 26. [Clinical analysis of 87 cases of testicular tumor].
    Zheng LW; Li FB; Liu RZ; Ji RG; Zhao ZW
    Zhonghua Nan Ke Xue; 2005 Jun; 11(6):445-7. PubMed ID: 15999491
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Current management of stage I testicular non-seminomatous germ cell tumours.
    Pectasides D; Pectasides E; Constantinidou A; Aravantinos G
    Crit Rev Oncol Hematol; 2009 May; 70(2):114-23. PubMed ID: 18805019
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Non-risk-adapted surveillance in clinical stage I nonseminomatous germ cell tumors: the Princess Margaret Hospital's experience.
    Sturgeon JF; Moore MJ; Kakiashvili DM; Duran I; Anson-Cartwright LC; Berthold DR; Warde PR; Gospodarowicz MK; Alison RE; Liu J; Ma C; Pond GR; Jewett MA
    Eur Urol; 2011 Apr; 59(4):556-62. PubMed ID: 21190791
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Testicular pain as the initial presentation of testicular neoplasms.
    Wilson JP; Cooksey G
    Ann R Coll Surg Engl; 2004 Jul; 86(4):284-8. PubMed ID: 15239873
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [A clinico-statistical study of testicular tumors--a reevaluation of 90 cases at the Nagasaki University Hospital and affiliated hospitals].
    Nomata K; Nisimura N; Taniguchi K; Kanetake H; Shindo K; Saito Y; Shimada O; Tsuda N; Tasaki T; Harra T
    Gan No Rinsho; 1988 Aug; 34(9):1115-20. PubMed ID: 2845172
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Management of poor-prognosis or relapsed germ-cell cancer.
    Daugaard G
    BJU Int; 2009 Nov; 104(9 Pt B):1392-7. PubMed ID: 19840019
    [No Abstract]   [Full Text] [Related]  

  • 32. Indications and results of surgery after chemotherapy of testicular tumors (NSGT and seminoma).
    Donohue JP
    Prog Clin Biol Res; 1988; 269():451-9. PubMed ID: 2839850
    [No Abstract]   [Full Text] [Related]  

  • 33. [Testicular germ cell tumors late relapses].
    Durand X; Avances C; Flechon A; Mottet N;
    Prog Urol; 2010 Jun; 20(6):416-24. PubMed ID: 20538205
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Is risk-oriented therapy in stage I non-seminoma tumor advisable?].
    Krege S; Rübben H
    Urologe A; 1993 May; 32(3):171-5. PubMed ID: 8390119
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Retroperitoneal lymph node dissection in patients with low stage testicular cancer with embryonal carcinoma predominance and/or lymphovascular invasion.
    Stephenson AJ; Bosl GJ; Bajorin DF; Stasi J; Motzer RJ; Sheinfeld J
    J Urol; 2005 Aug; 174(2):557-60; discussion 560. PubMed ID: 16006891
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Changing epidemiologic features of testicular germ cell cancer in Germany: corroboration at population level.
    Stang A; Rusner C; Stabenow R
    Urol Oncol; 2013 Nov; 31(8):1839-40. PubMed ID: 24035419
    [No Abstract]   [Full Text] [Related]  

  • 37. Randomized phase III trial comparing retroperitoneal lymph node dissection with one course of bleomycin and etoposide plus cisplatin chemotherapy in the adjuvant treatment of clinical stage I Nonseminomatous testicular germ cell tumors: AUO trial AH 01/94 by the German Testicular Cancer Study Group.
    Albers P; Siener R; Krege S; Schmelz HU; Dieckmann KP; Heidenreich A; Kwasny P; Pechoel M; Lehmann J; Kliesch S; Köhrmann KU; Fimmers R; Weissbach L; Loy V; Wittekind C; Hartmann M;
    J Clin Oncol; 2008 Jun; 26(18):2966-72. PubMed ID: 18458040
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Surgical aspects in the treatment of patients with testicular cancer.
    Richie JP
    Hematol Oncol Clin North Am; 1991 Dec; 5(6):1127-42. PubMed ID: 1663937
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of radiation therapy in the treatment of testicular germ cell tumors.
    Marks LB; Anscher MS; Shipley WU
    Hematol Oncol Clin North Am; 1991 Dec; 5(6):1143-72. PubMed ID: 1663938
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metachronous bilateral testicular germ cell tumors: report of two cases.
    James FV; Kumar A; Jayaprakash PG; Mathews A
    J Cancer Res Ther; 2009; 5(3):206-7. PubMed ID: 19841564
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.